G702-6013 Screening compound: N-[(2,5-dimethoxyphenyl)methyl]-2-(4-methylphenyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-amine

G702-6013 Screening compound: N-[(2,5-dimethoxyphenyl)methyl]-2-(4-methylphenyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-amine
G702-6013 Screening compound: N-[(2,5-dimethoxyphenyl)methyl]-2-(4-methylphenyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound G702-6013
N-[(2,5-dimethoxyphenyl)methyl]-2-(4-methylphenyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G702-6013

Molecular Formula

C25H27N5O2 (C25 H27 N5 O2)

Compound Name

N-[(2,5-dimethoxyphenyl)methyl]-2-(4-methylphenyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-amine

IUPAC name

N-[(25-dimethoxyphenyl)methyl]-2-(4-methylphenyl)-5H6H7H8H-[124]triazolo[32-b]quinazolin-9-amine

SMILES

Cc(cc1)ccc1-c1nn2c(NCc(cc(cc3)OC)c3OC)c(CCCC3)c3nc2n1

InChI

InChI=1S/C25H27N5O2/c1-16-8-10-17(11-9-16)23-28-25-27-21-7-5-4-6-20(21)24(30(25)29-23)26-15-18-14-19(31-2)12-13-22(18)32-3/h8-14,26H,4-7,15H2,1-3H3

InChI Key

VYCXGWGXPILXNZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27152111

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.165

Distribution Coefficient, logD

5.165

Water Solubility, LogSw

-5.00

Polar Surface Area

58.389

Acid Dissociation Constant (pKa)

14.28

Base Dissociation Constant (pKb)

3.81

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

G702-6013 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G702-6013 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G702-6013?
Check Price and Availability of G702-6013, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G702-6013 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G702-6013
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G702-6013
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G702-6013 available by request